Your browser doesn't support javascript.
Automated Quantification of CT Patterns Associated with COVID-19 from Chest CT.
Chaganti, Shikha; Grenier, Philippe; Balachandran, Abishek; Chabin, Guillaume; Cohen, Stuart; Flohr, Thomas; Georgescu, Bogdan; Grbic, Sasa; Liu, Siqi; Mellot, François; Murray, Nicolas; Nicolaou, Savvas; Parker, William; Re, Thomas; Sanelli, Pina; Sauter, Alexander W; Xu, Zhoubing; Yoo, Youngjin; Ziebandt, Valentin; Comaniciu, Dorin.
  • Chaganti S; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Grenier P; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Balachandran A; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Chabin G; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Cohen S; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Flohr T; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Georgescu B; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Grbic S; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Liu S; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Mellot F; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Murray N; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Nicolaou S; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Parker W; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Re T; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Sanelli P; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Sauter AW; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Xu Z; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Yoo Y; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Ziebandt V; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
  • Comaniciu D; Hôpital Foch, Suresnes, France (P.G., F.M.), Donald and Barbara Zucker School of Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA (S.C., P.S.), Siemens Healthinners, Bangalore, India (A.B.), Siemens Healthineers, Forchheim, Germany (T.F., V.Z.), Siemens Healt
Radiol Artif Intell ; 2(4): e200048, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-2098029
ABSTRACT

PURPOSE:

To present a method that automatically segments and quantifies abnormal CT patterns commonly present in coronavirus disease 2019 (COVID-19), namely ground glass opacities and consolidations. MATERIALS AND

METHODS:

In this retrospective study, the proposed method takes as input a non-contrasted chest CT and segments the lesions, lungs, and lobes in three dimensions, based on a dataset of 9749 chest CT volumes. The method outputs two combined measures of the severity of lung and lobe involvement, quantifying both the extent of COVID-19 abnormalities and presence of high opacities, based on deep learning and deep reinforcement learning. The first measure of (PO, PHO) is global, while the second of (LSS, LHOS) is lobe-wise. Evaluation of the algorithm is reported on CTs of 200 participants (100 COVID-19 confirmed patients and 100 healthy controls) from institutions from Canada, Europe and the United States collected between 2002-Present (April 2020). Ground truth is established by manual annotations of lesions, lungs, and lobes. Correlation and regression analyses were performed to compare the prediction to the ground truth.

RESULTS:

Pearson correlation coefficient between method prediction and ground truth for COVID-19 cases was calculated as 0.92 for PO (P < .001), 0.97 for PHO (P < .001), 0.91 for LSS (P < .001), 0.90 for LHOS (P < .001). 98 of 100 healthy controls had a predicted PO of less than 1%, 2 had between 1-2%. Automated processing time to compute the severity scores was 10 seconds per case compared to 30 minutes required for manual annotations.

CONCLUSION:

A new method segments regions of CT abnormalities associated with COVID-19 and computes (PO, PHO), as well as (LSS, LHOS) severity scores.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Language: English Journal: Radiol Artif Intell Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Language: English Journal: Radiol Artif Intell Year: 2020 Document Type: Article